US Stock MarketDetailed Quotes

NAMS NewAmsterdam Pharma

Watchlist
  • 19.190
  • -0.250-1.29%
Close Jun 14 16:00 ET
  • 19.190
  • 0.0000.00%
Post 16:00 ET
1.73BMarket Cap-7107P/E (TTM)

NewAmsterdam Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

NewAmsterdam Pharma Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

--

Revenue(YoY)

1.40M

-83.76%
EPS(YoY)

-1.06

-107.84%
Analyst Rating

Strong Buy

May 31, 2024

NewAmsterdam Pharma Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 8 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: EUR

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 1.830M--
--2024/Q2-- / 1.105M--
--2024/Q11.304M / 1.607M--
--2023/Q4-- / 1.767M--
--2023/Q2-- / 1.950M--
--2023/Q1-- / 1.467M--
--2022/Q4-- / 1.750M--
--2022/Q3-- / 3.500M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 1.830M--
--2024/Q2-- / 1.105M--
--2024/Q11.304M / 1.607M--
--2023/Q4-- / 1.767M--
--2023/Q2-- / 1.950M--
--2023/Q1-- / 1.467M--
--2022/Q4-- / 1.750M--
--2022/Q3-- / 3.500M--
--------
--------

Unlock Free Earnings Estimates

NewAmsterdam Pharma Earnings Reports

  • 10-Q: Quarterly report

    May 8 16:39 ET

  • NewAmsterdam Pharma | 10-K: Annual report

    Feb 28 08:02 ET

  • NewAmsterdam Pharma | 6-K: Report of foreign private issuer (related to financial reporting)

    Aug 7, 2023 07:24 ET

  • NewAmsterdam Pharma | 6-K: Report of foreign private issuer (related to financial reporting)

    Jun 9, 2023 21:39 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: May 31, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg